BSECompany Update12h ago · 31 Aug 2026, 04:29 pm

Announcement under SEBI Listing Regulations regarding schedule of Institutional Investor meet.

Global Health Ltd · 543654

✦ AI SummaryMgmt Change

Global Health Ltd (MEDANTA) has announced a schedule for an Institutional Investor meet on September 8, 2026, in Gurugram, with no unpublished price sensitive information to be shared.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

accaff4f-cb6a-4f25-9537-6f318aadc6a9.pdf

pdf

Download →
View document text
August 31, 2026 Ref:- GHL/2026-27/EXCH/ 49 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Schedule of Analysts/Institutional Investors Meeting. Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company’s Management will meet Investors/Analysts as per the below schedule: Date of Meeting Name of Investor/Analyst Type of Place of Meeting Mode of Firm Meeting Meeting September 8, Matthews International One to One Gurugram In person 2026 Capital Management September 8, Baillie Gifford One to One Gurugram In person 2026 Please note that, no Unpublished Price Sensitive Information is proposed to be shared, thereat. Note: Please note that the above meeting is subject to change in case of any unforeseen circumstances, on the part of Analysts/Investors/Company. Kindly take the above on record. For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M.No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319